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Abstract 
                                                 
1 This text was written following a presentation in English: Simon E. 
Non-conventional treatment of HIV/AIDS in Benin, Workshop 
NAARSP, AIDSIMPACT Satellite, 8th International Conference, MMSH, 
Aix-en-Provence, 01 July 2007. The written French version of the 
presentation was translated by Taï Walker (tai.wordstuff@gmail.com). 
The text has been rewritten and edited in collaboration with Sharon 
Calandra (dakarenglish@yahoo.com).  
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The beginning of the AIDS epidemic saw the appearance in Africa of 
myriad manufactured herbals indicated in the case of AIDS. This paper 
considers these new therapeutic treatments as social objects and situates 
them in the wider array of available therapeutic resources. This study 
examines this category of medicines by considering the relationships 
between imported manufactured-herbal and locally-produced “neo-
traditional” remedies. These relationships pertain to processes of 
instrumentalization, to ideas of similarity or difference and are explored 
by combining the examination of packaging and advertising materials 
with the analysis of discourses from both prescribers and consumers. 
 
Keywords: manufactured herbals, alternative medicine, neo-traditional 
medicine, prescription, consumption, health globalization, AIDS. 
 
 
At the beginning of the 21st century various manufactured herbals 
appeared in the therapeutic space of AIDS in Africa. These 
products were multiple compounds, including plant extracts, 
vitamins or minerals that border on health, nutrition and 
cosmetics.  
 
As a social object, no treatment can be understood unless it is 
situated in the locally available therapeutic recourses (Dagognet, 
1964). Different links are forged between the imported 
manufactured herbals and “improved traditional remedies” 
(Simon, forthcoming).2 New therapists (homoeopaths, 
 
2 “Improved traditional medicines” are also called “traditional 
medicines,” “phytotherapeutic products,” and “improved remedies.” 
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nutritionists, naturpaths, etc.) are involved in the promotion of 
“traditional medicines,” “improved traditional remedies” or 
“African phytotherapeutic products.” They undergo a local 
transposition, while simultaneously relying on the revival of 
traditional therapies (Simon, 2003; Le Marcis 2004). Also, many 
neo-traditional therapists3 borrow new therapeutic techniques 
(reflexology, acupuncture, French phytotherapy, Chinese 
phytotherapy) and use imported herbal remedies, vitamins, 
dietary supplements and even pharmaceutical drugs with 
unconventional indications (e.g. AIDS indication for aspirin). 
 
“Traditional,” “neo-traditional,” “biomedical” and “alternative” 
are thus not separate and distinct categories but rather pluralist 
categories resulting from rapid movement and changes in a 
global world. Ayurveda has become an alternative medicine 
through its exportation to the West (Zimmerman, 1995), taking a 
reverse path, many of these new treatments have become neo-
traditional4 through their exportation to Africa. Nevertheless, it 
seems to be relevant to uphold a distinction, which is not a matter 
of convention, between traditional treatments, neo-traditional 
 
These products are traditionally inspired (with real or invented filiations) 
but are distinguished from “recipes” because of their “readymade” 
presentation. The packaging may be combined with a label, directions or 
even advertising.  
3 Neo-traditional therapies mobilize doctrines, beliefs, rituals and 
practices that interact with the “mainstream” of biomedicine by 
combining multiple sources of inspiration (local or imported tradition, 
alternative health practices). Additionally, they are founded on a 
plurality of sources for legitimacy (Pordié, Simon, forthcoming). 
4 This includes all products promoted by neo-traditional therapists 
(Egrot, 2007, Simon, forthcoming).  
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treatments, biomedical treatments or pharmaceutical medicines 
and alternative treatments (Tan, 1989). Also, when dealing with 
these treatments both in terms of their filiations with the 
alternative sector and their insertion into the neo-traditional 
healthcare sector (for improved traditional treatments), this 
article intends to provide several elements in understanding the 
constant expansion of their supply and the craze they trigger 
locally.   
 
Method and corpus 
Adopting the approach introduced by Akrich (1995), this article 
undertakes to portray manufactured herbals, using interviews, but 
also all the information provided in the packaging, instructions 
and documentation that circulate with the products. The 
description of these materials makes it possible to understand 
how a treatment “by its very form defines the actors and the 
relations between these actors, attributes certain competencies to 
these actors and supposes a certain environment in order to 
‘function’” (Akrich, 1995, p. 129).  
 
The results presented here come from an ethnographic study 
(semi-directed interviews, in-site observations, collection of 
documentary) conducted in Benin between 2005 and 2007 of 
various actors in the production, distribution and consumption of 
neo-traditional treatments for AIDS. Limited surveys were 
conducted in Lomé (Togo). Semi-closed questionnaires were also 
administered at three sites for biomedical care for PLHIV (in 
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Cotonou and Porto Novo) regarding the use of neo-traditional 
treatments for AIDS. Approximately 70 treatments were 
collected for which just over 20 must be counted as imported 
products. Imported treatments came from North America (USA), 
from Europe (France, Czech Republic and Malta), from Australia 
(Hutt River5) and from China. 
 
For the purpose of this article, imported Chinese neo-traditional 
products for AIDS will be included in the same category as 
western manufactured herbals. This choice was made because 
they share a number of strategies to position themselves in the 
local therapeutic scene. Moreover, it has been noted that these 
products make a detour to the North before arriving to the 
continent. The literature from the Tianshi Company (see below) 
circulating in Benin has been developed in part from translated 
documents intended for the American public, as seen in the 
numerous references to the FDA (Food and Drug Administration: 
regulatory agency). Raw materials can also make this detour, as 
in the case of “Immuboost”, promoted by a Burkinabe. This 
product, which also circulated in Togo, is composed of Chinese 
mushrooms imported from the USA. Hence, the local symbolic 
construction of these treatments is also based on the meaning and 
uses that have been ascribed in the North. However, it is 
advisable not to generalize; many Chinese treatments circulating 
in Benin have not taken this detour through the West. Chinese 
medicine has been known in Benin since the communist period 
 
5 Hutt River is an independent frontier principality in Australia. 
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when several collaborations were established between Benin and 
China. Thus, currently in Cotonou, there are three Chinese 
medicine clinics (acupuncture and reflexology). Also, many 
biomedical Chinese treatments circulate within the framework of 
the informal drug market. Their symbolic construction as it 
occurs in the North is hardly relevant in understanding the 
meaning attributed to them locally. It is understood that the same 
object can be the support for varied social interpretations 
depending on whether it is in line with  Chinese, western or 
African local therapeutic supply (Hsu, 2002). 
 
Circuits for diffusion of these treatments and context of 
emergence 
The appearance of alternative AIDS treatments is relatively 
recent and coincides with their local arrival whatever the 
indications. Numerous undertakings specialized in manufactured 
herbal products have occurred since 2003: Forever Living 
Products6 (FLP) (USA) in 2003, Mariandina (provenance 
unknown) in 2005, Bio-Citrus (France) in 2006, etc. During this 
same period, the Tianshi Corporation, specializing in traditional 
Chinese medicines, was established in 2004. 
 
All of these companies function using a direct sales network: the 
products are sold by distributors who purchase a batch of 
products at a preferential rate and/or receive a percentage on 
every new distributor’s signed contract. Reaching a specific rank 
 
6 About FLP see Desclaux, 2008. 
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as distributor authorizes the opening of a shop. Tianshi shops 
have flourished over the last few years in Cotonou. The various 
companies have large product catalogues, including these that 
have an AIDS indication: “Aloe vera” from FLP and “Spirulina” 
from Tianshi, etc. 
 
The “bio,” “natural health” and “health food” shops that arrived 
in Cotonou early in the 21st century also offered alternative AIDS 
treatments. These shops stock French medicinal plants in sachets, 
imported phytotherapy products, health food products, local food 
products presented as “healthy” (gari, flour, biscuits and even 
sodabi7!) and sometimes a few improved traditional treatments 
and specialized literature. One of these shops continuously 
advertised several herbal preparations, imported or not, with an 
AIDS indication (“Sutherlandia”, “Noni”, “Antilaleka”). 
 
Medical practices or clinics offering manufactured herbals appear 
here and there, practicing homoeopathy, reflexology, Chinese 
medicine, phytotherapy, etc. In Cotonou, at least one clinic 
(Nesto-Pharma) offers AIDS treatment (prescribed by healer, a 
trained pharmacist): “Virusinest”, “Virusinest Duo” and 
“Virusinest Complex”. The products are made in the Czech 
Republic by the Nesto-Pharma Company and imported into 
Benin. 
 
 
7 Alcohol made from distilled palm wine. 
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Finally, various pharmacies in Cotonou have been selling 
manufactured herbals for several years. These products are 
usually placed next to African traditional treatments and to a few 
food products (honey, olive oil). Included among these products 
are a few that circulate in the therapeutic space of AIDS, 
including those from FLP (bottles of Aloe vera and other 
products) and Bio-Citrus (bottles of fermented papaya, sachets of 
spirulina). 
 
Products also circulate in the biomedical healthcare system 
through various members of the medical profession, who receive 
visits from medical representatives and distributors from the 
companies involved in the direct sales network. Physicians 
prescribing ARTs have thus recently begun to prescribe 
manufactured herbals or vitamin complexes such as 
“Immunicomplex”, “Immunoboost”, “Viralgic”. 
 
Therefore, these products mainly circulate over the counter. It is 
advisable to first consider the arrival of these products and 
examine this in connection with the permeability of the health 
markets in the South, which have no or few regulations 
concerning food supplements (products previously absent from 
the local healthcare market) and herbal products. Certainly, in 
industrialized countries, regulatory guidelines for herbal 
medicine might vary from one country to another (Dobos, et al., 
2005). Yet, the fact remains that the lack of regulation and 
legislation contributes to this sector’s economic attraction with 
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the countries of the South thus becoming potential economic 
avenues for all kinds of products coming from the North and/or 
East. For example, in Benin, the registration of food 
supplements, which has only been implemented since 2006, is 
recommended but not obligatory. Registration is conducted at the 
Direction des Pharmacies and the cost of this step (compared to 
the cost for the AMM, French acronym for pharmaceuticals 
marketing authorization) is more than modest (25,000 FCFA). It 
is merely a formality because little information concerning the 
product’s manufacture and stability is required. In addition, no 
definition of “food supplements” has been adopted. The Director 
of Pharmacies, when asked about this, considered that this was 
simply a question of dosage (cf. the vitamins classified as food 
supplements or medicines).  
 
At the same time, there are no specific regulatory laws 
(simplified marketing authorization as in France; inclusion in 
food supplement classifications as in the USA, etc.) for plant-
based manufactured preparations. Local products circulate 
outside any regulatory framework while imported products are 
subjected to pharmaceutical drug regulation. It is therefore not 
surprising to observe in the field that the majority of alternative 
therapeutic products, circulating in the South are presented as 
food supplements, while not abstaining from unsubstantiated 
claims regarding their ability to prevent, care for or cure this or 
that pathology.  
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The advertising booklets circulating with some products include 
a number of circuitous statements that attempt to make the reader 
forget that, despite their legal status, these products claim to have 
properties normally ascribed to medicines. “Viralgic” is a case in 
point. This product from France has an AIDS indication and is 
only marketed in Africa and Asia. The pharmacist who 
“invented” it explained that this is not a matter of choice, but 
rather the result “of administration.” “The French regulations 
pertaining to phytotherapy are too stringent.” He also added that 
it is impossible to conduct research in phytotherapy in the North, 
where he “received a demurrer.” Prohibited in France because it 
is classified as a medicine, this product was tested in Burkina 
Faso, Togo, Côte d’Ivoire and Guinea, and presented as a 
“psychotherapeutic formula,” an “officinal formula of 
phytotherapy,” a “preparation” or an “alicament” (functional 
food). The company moved to Hutt River and was able to obtain 
marketing authorization for its product as a “phytotherapeutic 
pharmaceutical,” and positions itself as such today.  
 
How to become a local medicine of AIDS?  
Among the collected treatments, some internationally known 
panaceas such as Aloe, Ginseng, Morinda and some minerals or 
vitamin complexes have been noted in the literature as being used 
by people living with AIDS who reside in the treatment’s country 
of origin (Cho et al., 2006; Eurin, 1997). On the contrary, the 
majority of products marketed in the South for AIDS were 
marketed in the North (when they were marketed) for other 
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indications (even in the case of the panaceas cited above). The 
Nesto-Pharma Company did not have a single product in its 
catalogue with an AIDS indication before establishing itself in 
Benin (one should note that at the same time it developed a 
product for malaria). By the same token, the Web sites for the 
FLP Company, Bio-Citrus or Tianshi make no reference to 
treating AIDS. The product brochures that position themselves as 
treatment for AIDS usually do not mention this indication; 
instead they list: skin diseases, digestive disorders, haemorrhoids, 
allergies, high cholesterol levels, depression, etc. in the case of 
“Aloe vera” from FLP; cancer prevention, inflammation, mental 
disturbances, blood-clots in the case of “Anti-Oyxdant/Omega3” 
from NL France. 
 
On the other hand, the promotional leaflets from medical 
representatives, distributors or even in the delivered-locally 
documentation presenting tables at the end of the booklet that 
associate the pathologies and the recommended products, 
systematically refer to AIDS. Product distributors with direct 
sales network structures regularly visit members of the medical 
profession dispensing treatments as well as patient associations, 
just as they visit general practitioners, government officials, 
shopkeepers, etc. The sale of treatments takes into account the 
demand and the needs of potential clients. And AIDS, with its 
high prevalence in the South (and also malaria), provides an 
economic market for the companies that set up locally.  
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However, unlike the locally improved products, for which the 
AIDS disease played a catalytic role (Dozon, 2001), the strategy 
used by the promoters of imported manufactured products is not 
necessarily centered on the disease AIDS. In the particular case 
of Chinese import products, in 2004 traditional Chinese 
medicines was officially integrated in the Chinese national 
progam of fight against AIDS. But, the qualitative analysis of 
collected data show that there is no mention for Tangcao either, 
which was the only product approved by the Chinese State Food 
Drug Administration in 2006 or the Chuankezhi injection that has 
been tested for AIDS in Yunnan Province since 2006 (Micollier, 
2007).8 And, like in China, part of AIDS products is composed of 
common plants of popular Chinese medicine (e.g. the Astragalus 
used in “Immuboost”). Yet, no reference is made to its use in 
China for an AIDS indication. As is true for treatments from the 
West, marketing around these products further targets the 
following indications: well-being (weight loss, skin beauty, anti-
aging, balance, renewed energy), diabetes, arterial hypertension, 
cardiovascular diseases and high cholesterol with a predilection 
for cancer. All the sectors in which alternative treatments are 
usually positioned in the North are found here. Moreover, this 
concerns just some of the chronic or acute pathologies appearing 
in the South that continue to receive only limited care in the local 
 
8 In other African countries, Chinese medicines are invested in the field 
of AIDS and are controversial objects portrayed by the press as being 
the same as traditional African treatments. This is the case, for example, 
in Congo-Kinshasa (Cf. “Controverse autour de la médecine chinoise,” 
La conscience, 21/01/07).  
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biomedical healthcare system. This positioning thus corresponds 
to new emerging health needs, especially among the “middle” or 
well-off class. 
 
The inventory of properties of manufactured herbals intended for 
AIDS (packaging, brochures) or the documentation circulating 
with them (advertisements, product catalogues, brochures 
distributed by medical representatives) casts light on the position 
of these products as food supplements that “restore” the 
organism, such as immunostimulants and antioxidants. 
References to cancer are recurrent in these products’ booklets 
and are usually linked to the notion of antioxidant; for example: 
“prevention: cancer, inflammation, mental disturbances, blood 
clots” (NL France); “antioxidant used in cancers” (“A-Beta-
Care” from FLP). The same arguments are found for Chinese 
neo-traditional products: “revitalizes the activity of the 
lymphocytes that can eliminate cancerous cells” (“Chitosan” 
from Tianshi). In an equally significant manner, the Nesto-
Pharma products intended for AIDS have been developed based 
on a formula for the treatment of cancer, “Anticar.” The promoter 
explained that he initially prescribed “Anticar” for seropositive 
patients, but the lack of response led him to modify the 
composition resulting in “Virusinest.” Since the connections 
between the two pathologies are very strong, the therapist 
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explained during our last interview that he was in the process of 
treating several patients with prostrate cancer with “Virusinest”.9
 
In fact, the action of “reducing the oxidative stress” in the “battle 
against free radicals” was initially described in the sector of 
cancer care. And this inflation of discourses around the notion of 
antioxidants is related to the link between AIDS and cancer 
characteristic of the nosological representations conveyed in 
Western alternative therapeutic models. This transference of 
cancer towards AIDS was quite topical in the 1990s (since AZT 
also comes from the therapeutic space of cancer, a parallel was 
perhaps drawn and then transposed to another paradigm). For 
example, the French Beljanski Company, which is currently 
based in the USA, (and was accused of charlatanry in France10) 
comes to mind. After having developed products for cancer, 
which are still marketed today in the USA and available via the 
Internet in France, the company marketed a product for AIDS in 
the 1990s (there is no sign of this product today for this 
indication). 
 
The idea of food supplements enabling the restoration of the 
organism brings us back to the notion of food supplement, not as 
 
9 Concerning the circulation of treatments, therapeutic theories also 
follow the southern route with the same shift from cancer towards AIDS; 
this is the case of “biological decoding” of Claude Sabbah (personal 
communication from A. Sarradon). 
10 In 2002, Act Up, AIDES and the League against Cancer filed a civil 
suit against the Beljanski products: 
http://www.actupparis.org/article500.html 
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understood in its legal status but as a property attributed to a 
product. This can take two forms: (1) purging: “detoxification of 
the body” (“Tianshi detoxifying tea”), “favouring the process of 
natural elimination” (“Energy Pure”, NL France) and (2) 
tonification: “revitalization, invigoration” (“Spirulina”, Evans 
Carter) and a “roborant, nutritive substance displaying a rapid 
regeneration of the convalescent organism” (“Virusinest 
Complex”). 
 
The idea that good nutritional balance makes it possible to avoid 
“clogging up” the body and supplies it with elements necessary 
for proper functioning is widely shared in the North and is a 
matter of common sense. This representation of diet is 
meaningful in societies with growing medicalization (or over-
medicalization) where health involves the sectors of beauty, 
sports, diet, etc. It is also characteristic of societies where there is 
overconsumption. This type of representation is spreading in the 
South among the middle class. An advertisement for a product 
that is currently aired on Beninese television channels (Jago milk 
is presented by a man dressed like a chemist or doctor as a 
product containing 35 vitamins and minerals necessary for a 
child’s healthy development) and the numerous radio programs 
on nutrition bear witness to this preoccupation. It should be 
noted, not without cynicism, that the arrival of food supplements 
in the therapeutic space of AIDS was undoubtedly also favored 
by international recommendations pertaining to nutritional 
support for people living with AIDS. It is known that 
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recommendations were formulated subsequent to research 
conducted mainly in Africa, which showed that the consequences 
of AIDS were all the more serious when the sick person is 
malnourished or undernourished. Let us remember that a food 
supplement is not intended to offset malnutrition, but to 
supplement a normal diet.  
 
How does supply meet demand? 
These treatments carry therapeutic ideas and models with them 
that come from Western societies, but how do they fit into the 
local healthcare supply? To respond to this question, the  
discourses of actors from two moments in the “biography of 
pharmaceuticals” (Geest, Whyte, Hardon, 1996) will be 
emphasized: prescription and consumption. 
 
If an inventory equivalent to that described above11 is drawn up 
for the improved traditional treatments circulating in Benin, it has 
been observed that these products do not a priori occupy the 
same therapeutic territories and that they develop distinct 
nosological categories. The development of neo-traditional 
treatments for AIDS is usually based on previous treatments for 
viral or bacterial pathologies (herpes and hepatitis are the most 
frequently cited), treatments for local nosological categories 
considered to be precursors of AIDS (such as Goxuxu: weight 
loss) and on treatments for pathologies termed “black” or 
 
11 The packaging standards of the products are often more rudimentary, 
and the critical apparatus circulating with these treatments are often 
insufficient or even lacking. 
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“African,” such as drepanocytosis. The majority of these 
products are presented either as local alternatives (in the situation 
of limited accessibility to ARTs and/or without the secondary 
effects of ARTs) or as treatments capable of curing AIDS (Simon 
et al., 2007).  
 
Returning to manufactured herbals, we have said that they are 
mainly positioned as immunostimulants. The antiviral property 
is, however, not absent. For some twenty imported products 
circulating in Benin and Togo, eight professed antiviral 
properties in addition to immunostimulation. 
 
The antiviral dimension sometimes only refers to the 
opportunistic diseases associated with AIDS: anti “herpes 
buccalis or genitalis, mycoses, shingles” (packaging for the gel 
form of “Immunicomplex”), anti “herpes, antiviral” 
(“Immuboost”) and “herpes, shingles, Karposi’s sarcoma” 
(“Herbpower"). And, it often remains secondary. The treatment 
proposed by Tianshi is, for example, composed of 
immunostimulants and tonics (for which “Spirulina” is also 
presented as being antiviral), and the definition given for AIDS 
in their catalogue puts the least emphasis on the 
immunodepressive dimension: “disease that destroys the immune 
system of the body and exposes it to all kinds of diseases. AIDS 
is characterized by the loss of appetite, weight loss, constant 
headaches, faeces, etc.”. 
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Finally, it has been observed that two products initially 
professing an anti-HIV activity are placed differently today. 
“Virusinest”, whose promoter withdrew it from the market (he 
distributed it to local physicians), today affirms that analyses 
conducted among patients do not allow for maintaining the anti-
HIV assertion. By the same token, an attentive reading of the 
successive brochures for “Viralgic” reveals a change in the 
product’s position from an antiretroviral promising to render the 
virus undetectable (brochure 1) to an immunostimulant (result of 
trials published on the Web site), by way of an antiviral, anti 
“herpes, influenza, chickenpox for healthy persons” (application 
for registration in Benin). Upon questioning, the product’s 
“inventor” reaffirmed the antiviral quality of the product but 
noted that it is locally perceived as an immunostimulant. The 
interviews conducted with the prescribers of ARTs using these 
manufactured herbal products show that, in fact, these products 
are recognized for the quality of immunostimulation or the 
capacity to treat opportunistic diseases (dermatoses, herpes, 
Kaposi’s sarcoma). Conversely, prescribers involved in the use of 
improved traditional medicines mention an anti-HIV activity 
instead (“Tobakoaks”, “Api-Sida”, “Medoleme”, etc.). 
 
The corollary to the immunostimulant dimension is the fact that 
these products are presented as complements to ARTs.  In the 
case of companies specializing in alternative products, they claim 
there is a link to biomedical care for all their products (“there is 
no medicinal interaction,” FLP catalogue; “does not replace 
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treatment with ARTs” and “this treatment can also be 
administered to patients under ARTs,” “Viralgic brochure”). 
Among prescribing physicians who have chosen these products, 
this is the determining dimension: “if this is something that 
requires stopping ARTs; that’s just not true” (physician 
prescribing ARTs, Lomé). Otherwise, their singularity is that 
they divide the complementary qualities into two phases: pre-
inclusion with ARTs to delay the administration of ARTs and 
post-inclusion to curb the development of opportunistic diseases: 
“from contamination and seroconversion from 1,000 to a 600 
CD4 count. To prevent decreases in the CD4/CD8 ratio and the 
level of CD4 lymphocytes to maintain a sound immune system; 
treatment for life; after contamination dating several years, 
having a lymphocyte level somewhere between 600 and 200 to 
improve the immune system by increasing or stabilizing the 
CD4/CD8 ratio to prevent opportunistic diseases and the rapid 
appearance of declared AIDS; with declared AIDS, below 200 
CD4 count. Complementing the treatment with ARTs to 
stimulate the production of lymphocytes to check viral 
opportunistic diseases” (“Viralgic brochure”). 
 
The fact that one must await eligibility for ARTs continues to be 
frequently misunderstood element. A televised debate in Benin 
organized on 1 December 2005 for World AIDS Day invited two 
opponents—the head of the PNLS (national program to fight 
AIDS) and a tradipractitioner who asserted that he cured AIDS—
and came to an abrupt end around this question. The journalist as 
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well as the tradipractitioner accused the PNLS director of not 
providing convincing arguments. Patients’ concern about waiting 
for eligibility for “amisin daho” (translation from Fon: “the great 
medicine”) is also understandable. The possibility for a 
prescribing physician to dispense an original (or even newly 
introduced, cf. below) pre-inclusion therapeutic treatment with 
ARTs weighs heavily on patients’ decisions (Simon et al. 2008).  
 
Very little information is available about the consumption of 
these products among people living with AIDS. However, the 
few interviews conducted with persons consuming manufactured 
herbals indicate that they are used for different reasons: to cure, 
to alleviate secondary effects of ARTs (lipodystrophy, nausea), to 
strengthen the organism and for skin problems (blemishes). Thus 
treatments are mostly used in combination with ARTs. Regarding 
the hope to be cured (although certainly no product has put forth 
such an allegation), it must be remembered that there is an 
intermediary link between the brochure and the consumer of 
products diffused in the framework of a direct sales network: the 
distributor. And in the case of FLP or the Thianshi group, the 
differences between the direct sales network and a pyramid 
business (prohibited for several years in Europe given its 
excesses) are not always clear. For example, as with the case for 
pyramid businesses, the distributor purchased a minimal stock 
that cannot be returned to launch activity. This promotes far-
fetched allegations. The sick consumers whom we interviewed 
referred to the testimonies reported by these distributors: “There 
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are people who have experienced it.” “When they did follow-up 
tests some time later, they found nothing, they were negative. 
That’s what motivates me, I want to get rid of the virus” (woman 
living with HIV, age 27).  
 
For all our interlocutors (consumers and prescribers), the 
professed arguments for the AIDS indication are in line with the 
discourses pertaining to the safety and efficacy of these products. 
While the arrival of these treatments is due to the lack of local 
regulation in the pharmaceutical sector and that a non-negligible 
percentage of them are sold within the framework of direct sales 
companies with questionable operations, it seemed that the 
consumers and prescribers place these objects on the side of 
safety and efficacy. One recurrent element is the asserted absence 
of aggressiveness or toxicity. For the AIDS indication, one can 
read: “no secondary effects” and “no resistances” unlike the 
ARTs… More generally, the documentation circulating with 
these products develops the problematic of iatrogenic 
pathologies, secondary effects, the high economic stakes around 
the medicine, the by-products of clinical tests in the South, etc. It 
is a prominent element in the decisions made by prescribers or 
consumers: “It’s natural. I like everything that is based on plants. 
Allopathy has its benefits, but also its limits. Since Hippocrates, 
there have been two schools of medicine, allopathy and the 
medicine of opposites, which led to homoeopathy. Our parents 
treated that way” (a midwife).  
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Anthropological literature pertaining to medicines has already 
described how, in the context of globalization, one sees both 
growing popularity and skepticism towards medicines that 
promote the appearance of other therapeutic models (Geest, 
Whyte, 2003). Thus, as Nichter underscores, a double movement 
can be observed favoring, on the one hand, pharmaceutical 
medicines and, on the other hand, a new relationship to the body, 
which together favor products dependent on traditional/neo-
traditional and alternative therapeutic models (Nichter, 1994). 
This contributes to the local incorporation of imported products. 
This can be seen, for example, in the fact that they are arranged 
beside each other in the pharmacies and “bio” shops, or in the 
fact that a few improved traditional treatments are included on 
the list of food supplements for the Direction des Pharmacies, 
with the comment “phytotherapy.” This shared platform masks 
the fractures that exist between imported manufactured herbals 
and improved traditional treatments.  
 
Nevertheless, manufactured herbals also advance technology 
enlisted in the production of their products. The “tradition” that 
characterizes the “improved traditional medicines” takes on a 
negative value for whatever is deemed “obsolete” and 
“ineffective” (Tan, 1999). It is contrary to the notion of 
“industrial technology” considered to be the gauge of effective 
know-how (precise calibration, repeated gestures, rapid 
innovations, etc.) and product safety. Hence, these products’ 
efficacy is related to their innovative capacity: “the active 
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principles are extracted, notably by solubilization in different 
solvents, maceration, distillation, etc. (…) according to the know-
how specific to the inventor: new technology in the area of 
phytotherapy” (Viralgic documentation). The galenic nature of 
Chinese neo-traditional treatments also includes them in 
modernity. In Asia, industrial production of products based on 
traditional knowledge began at the end of the 19th century 
(Afdhal F., Welsch R., 1998, Bode, 2002). This is much less 
frequent in the case of traditional African treatments except for a 
few products in particular from South Africa (such as 
“Sutherlandia” or “African Poteteos). Production is usually 
artisanal, and capsules and gels are still rare among local neo-
traditional treatments. Thus, traditional Chinese products that are 
strengthened by their success even within the pharmaceutical 
drug industry (e.g. arthemisine) are perceived as being 
particularly effective. The ease with which they are taken 
combined with the lack of the pronounced taste that is 
characteristic of a number of Beninese neo-traditional or 
traditional treatments (the bitterness gauging their efficacy) is 
another prevalent argument among consumers: “I also trust our 
tradition, but the Chinese treatment is easier to take” (man living 
with HIV, age 34). Emphasis is placed on the production 
processes that ensure proper preservation of the products. The 
FLP information gatherings begin with a film screening on the 
micro-industry, food safety, obtaining quality labels, etc. This 
type of argument is also found among the consumers, who 
explain their refusal to resort to improved traditional medicines: 
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“We know that the Americans have prepared the treatments in 
conditions that are possibly more hygienic, cleaner” (woman 
living with HIV, age 27).  
 
The distant origin of the treatments is also an element 
contributing to the attractiveness of these products. It should be 
noted that, despite being financially inaccessible for a large 
number of patients, the FLP “flagship” product is one of the best 
known among people living with HIV with the local name: 
“yellow bottle.” However, the exoticism, in the sense of 
unfamiliarity, is potentially dangerous. A seller who regretted the 
fact that the FLP products were no longer made with a recipe 
explained this with: “They changed the composition; the product 
is no longer as pure; we’re not duped.” A man living with HIV, 
who produces his own aloe juice, explained that he recalls having 
read that the aloe content was only 70%; “and what’s the rest? I 
prefer to make my stuff myself; it’s more natural.” Based on its 
incorporation into the industrial production chain, this exoticism 
risks pushing some of these products across the “line of combat” 
in the battle against pharmaceutical medicines. 
 
Conclusion 
The arrival of these products in the therapeutic space of AIDS in 
Africa should be seen in relationship to globalization (accelerated 
exchange of goods and ideas and the increased movement of 
people). Although the impact of globalization on the population’s 
access to medical care has now become the subject of relevant 
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studies, few or no studies have been conducted on globalization 
understood as the diffusion of alternative therapeutic products 
(marketing, circulation of information and knowledge concerning 
these products, modality of choice regarding available products, 
etc.). This article presents a few descriptive contours of this 
transfer, knowing that the recent arrival of these products can 
only lead us to observe the positions and discourses that are still 
in the process of developing. In this informative article, I wanted 
to restitute the information while taking into consideration the 
depth of the situation. This was intended as preliminary work on 
the development of a social critique of the structured and 
dominating power relationship existing around these medicines.  
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